TY - JOUR
T1 - Neither Blood Culture Positivity nor Time to Positivity Is Associated with Mortality among Patients Presenting with Severe Manifestations of Sepsis
T2 - The FABLED Cohort Study
AU - Paquette, Katryn
AU - Sweet, David
AU - Stenstrom, Robert
AU - Stabler, Sarah N.
AU - Lawandi, Alexander
AU - Akhter, Murtaza
AU - Davidson, Adam C.
AU - Gavric, Marko
AU - Jinah, Rehman
AU - Saeed, Zahid
AU - Demir, Koray
AU - Sangsari, Sassan
AU - Huang, Kelly
AU - Mahpour, Amirali
AU - Shamatutu, Chris
AU - Caya, Chelsea
AU - Troquet, Jean Marc
AU - Clark, Greg
AU - Wong, Titus
AU - Yansouni, Cedric P.
AU - Cheng, Matthew P.
N1 - Publisher Copyright:
© 2021 The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
PY - 2021/7
Y1 - 2021/7
N2 - Background: Sepsis is a leading cause of morbidity, mortality, and health care costs worldwide. Methods: We conducted a multicenter, prospective cohort study evaluating the yield of blood cultures drawn before and after empiric antimicrobial administration among adults presenting to the emergency department with severe manifestations of sepsis. Enrolled patients who had the requisite blood cultures drawn were followed for 90 days. We explored the independent association between blood culture positivity and its time to positivity in relation to 90-day mortality. Results: Three hundred twenty-five participants were enrolled; 90-day mortality among the 315 subjects followed up was 25.4% (80/315). Mortality was associated with age (mean age [standard deviation] in those who died was 72.5 [15.8] compared with 62.9 [17.7] years among survivors; P <. 0001), greater Charlson Comorbidity Index (2 [interquartile range {IQR}, 1-3] vs 1 [IQR, 0-3]; P =. 008), dementia (13/80 [16.2%] vs 18/235 [7.7%]; P =. 03), cancer (27/80 [33.8%] vs 47/235 [20.0%]; P =. 015), positive quick Sequential Organ Failure Assessment score (57/80 [71.2%] vs 129/235 [54.9%]; P =. 009), and normal white blood cell count (25/80 [31.2%] vs 42/235 [17.9%]; P =. 02). The presence of bacteremia, persistent bacteremia after antimicrobial infusion, and shorter time to blood culture positivity were not associated with mortality. Neither the source of infection nor pathogen affected mortality. Conclusions: Although severe sepsis is an inflammatory condition triggered by infection, its 90-day survival is not influenced by blood culture positivity nor its time to positivity. Clinical Trials Registration: NCT01867905.
AB - Background: Sepsis is a leading cause of morbidity, mortality, and health care costs worldwide. Methods: We conducted a multicenter, prospective cohort study evaluating the yield of blood cultures drawn before and after empiric antimicrobial administration among adults presenting to the emergency department with severe manifestations of sepsis. Enrolled patients who had the requisite blood cultures drawn were followed for 90 days. We explored the independent association between blood culture positivity and its time to positivity in relation to 90-day mortality. Results: Three hundred twenty-five participants were enrolled; 90-day mortality among the 315 subjects followed up was 25.4% (80/315). Mortality was associated with age (mean age [standard deviation] in those who died was 72.5 [15.8] compared with 62.9 [17.7] years among survivors; P <. 0001), greater Charlson Comorbidity Index (2 [interquartile range {IQR}, 1-3] vs 1 [IQR, 0-3]; P =. 008), dementia (13/80 [16.2%] vs 18/235 [7.7%]; P =. 03), cancer (27/80 [33.8%] vs 47/235 [20.0%]; P =. 015), positive quick Sequential Organ Failure Assessment score (57/80 [71.2%] vs 129/235 [54.9%]; P =. 009), and normal white blood cell count (25/80 [31.2%] vs 42/235 [17.9%]; P =. 02). The presence of bacteremia, persistent bacteremia after antimicrobial infusion, and shorter time to blood culture positivity were not associated with mortality. Neither the source of infection nor pathogen affected mortality. Conclusions: Although severe sepsis is an inflammatory condition triggered by infection, its 90-day survival is not influenced by blood culture positivity nor its time to positivity. Clinical Trials Registration: NCT01867905.
UR - http://www.scopus.com/inward/record.url?scp=85112508081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112508081&partnerID=8YFLogxK
U2 - 10.1093/ofid/ofab321
DO - 10.1093/ofid/ofab321
M3 - Article
C2 - 34307728
AN - SCOPUS:85112508081
SN - 2328-8957
VL - 8
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - 7
M1 - ofab321
ER -